Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial

Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage - Sembill - 2020 - Annals of Clinical and Translational Neurology - Wiley Online Library

Loop Alexandros A Polymeris

Stroke Alert on Apple Podcasts

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Use of direct oral anticoagulants in ICU patients. Part II – Clinical evidence

Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage - Sembill - 2020 - Annals of Clinical and Translational Neurology - Wiley Online Library

Brian Gilbert, PharmD, MBA, FCCM, FNCS on X: *from the rooftops* TXA is a narrow spectrum hemostatic agent. DOAC-associated ICH needs thrombin generation. I've never read anything that DOACs increase fibrinolysis so not sure why we put TXA in

Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial

Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage, Neurological Research and Practice